ATE247963T1 - Medikament zur behandlung von glaukoma und ischämischer retinopathie - Google Patents
Medikament zur behandlung von glaukoma und ischämischer retinopathieInfo
- Publication number
- ATE247963T1 ATE247963T1 AT99303513T AT99303513T ATE247963T1 AT E247963 T1 ATE247963 T1 AT E247963T1 AT 99303513 T AT99303513 T AT 99303513T AT 99303513 T AT99303513 T AT 99303513T AT E247963 T1 ATE247963 T1 AT E247963T1
- Authority
- AT
- Austria
- Prior art keywords
- treating glaucoma
- drug
- ischemic retinopathy
- mammal
- retinopathy
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 2
- 208000017442 Retinal disease Diseases 0.000 title abstract 2
- 206010038923 Retinopathy Diseases 0.000 title abstract 2
- 230000000302 ischemic effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Eye Examination Apparatus (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8674598P | 1998-05-26 | 1998-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247963T1 true ATE247963T1 (de) | 2003-09-15 |
Family
ID=22200630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99303513T ATE247963T1 (de) | 1998-05-26 | 1999-05-05 | Medikament zur behandlung von glaukoma und ischämischer retinopathie |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0985414B1 (de) |
| JP (1) | JP2000026297A (de) |
| KR (2) | KR100469188B1 (de) |
| AT (1) | ATE247963T1 (de) |
| AU (1) | AU762037B2 (de) |
| CA (1) | CA2272665C (de) |
| DE (1) | DE69910706T2 (de) |
| DK (1) | DK0985414T3 (de) |
| ES (1) | ES2204067T3 (de) |
| HU (1) | HUP9901728A3 (de) |
| IL (1) | IL130052A0 (de) |
| MY (1) | MY133222A (de) |
| NZ (2) | NZ335952A (de) |
| PT (1) | PT985414E (de) |
| TW (1) | TW581678B (de) |
| ZA (1) | ZA993528B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6956036B1 (en) | 2000-03-17 | 2005-10-18 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
| WO2001070702A1 (en) * | 2000-03-17 | 2001-09-27 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
| NZ551012A (en) * | 2000-06-02 | 2008-04-30 | Pfizer Prod Inc | Use of S-methyl-dihydro-ziprasidone administered via either the oral, parenteral (such as subcutaneous, intravenous, intramuscular, intrasternal and infusion techniques), rectal, intranasal or topical routes in doses ranging from 0.5 to 500 mg per day |
| CA2453837C (en) | 2001-07-20 | 2011-10-04 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2021262A1 (de) * | 1970-04-30 | 1971-11-11 | Cassella Farbwerke Mainkur Ag | Piperazinderivate |
| US4130646A (en) * | 1975-07-25 | 1978-12-19 | E. R. Squibb & Sons, Inc. | 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof |
| NZ196284A (en) * | 1980-02-29 | 1983-12-16 | Kefalas As | 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions |
| EP0233728A1 (de) * | 1986-02-11 | 1987-08-26 | Takeda Chemical Industries, Ltd. | 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung |
| US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
| US5350747A (en) * | 1989-07-07 | 1994-09-27 | Pfizer Inc | Heteroaryl piperazine antipsychotic agents |
| ZA9010081B (en) * | 1989-12-20 | 1991-10-30 | Merrell Dow Pharma | Method for the treatment of glaucoma |
| CA2036307C (en) * | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| PL188164B1 (pl) * | 1996-05-07 | 2004-12-31 | Pfizer | Trihydrat metanosulfonianu 5-{2-[4-1,2-benzizotiazol-3-ilo)-1-piperazynylo]etylo}-6-chloro-1,3-dihydro-2H-indol-2-onu i środek farmaceutyczny |
-
1999
- 1999-05-05 DE DE69910706T patent/DE69910706T2/de not_active Expired - Fee Related
- 1999-05-05 DK DK99303513T patent/DK0985414T3/da active
- 1999-05-05 PT PT99303513T patent/PT985414E/pt unknown
- 1999-05-05 EP EP99303513A patent/EP0985414B1/de not_active Expired - Lifetime
- 1999-05-05 AT AT99303513T patent/ATE247963T1/de not_active IP Right Cessation
- 1999-05-05 ES ES99303513T patent/ES2204067T3/es not_active Expired - Lifetime
- 1999-05-19 IL IL13005299A patent/IL130052A0/xx unknown
- 1999-05-19 TW TW088108219A patent/TW581678B/zh not_active IP Right Cessation
- 1999-05-21 CA CA002272665A patent/CA2272665C/en not_active Expired - Fee Related
- 1999-05-24 MY MYPI99002034A patent/MY133222A/en unknown
- 1999-05-25 ZA ZA9903528A patent/ZA993528B/xx unknown
- 1999-05-25 NZ NZ335952A patent/NZ335952A/xx unknown
- 1999-05-25 AU AU31242/99A patent/AU762037B2/en not_active Ceased
- 1999-05-25 HU HU9901728A patent/HUP9901728A3/hu unknown
- 1999-05-25 KR KR10-1999-0018748A patent/KR100469188B1/ko not_active IP Right Cessation
- 1999-05-25 NZ NZ50824699A patent/NZ508246A/xx unknown
- 1999-05-26 JP JP11146192A patent/JP2000026297A/ja active Pending
-
2003
- 2003-10-22 KR KR10-2003-0073635A patent/KR20030086544A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990088520A (ko) | 1999-12-27 |
| EP0985414B1 (de) | 2003-08-27 |
| NZ335952A (en) | 2001-01-26 |
| DE69910706D1 (de) | 2003-10-02 |
| AU3124299A (en) | 1999-12-02 |
| HUP9901728A2 (hu) | 2000-12-28 |
| EP0985414A2 (de) | 2000-03-15 |
| KR100469188B1 (ko) | 2005-01-31 |
| DE69910706T2 (de) | 2004-07-08 |
| ZA993528B (en) | 2000-11-27 |
| KR20030086544A (ko) | 2003-11-10 |
| MY133222A (en) | 2007-10-31 |
| JP2000026297A (ja) | 2000-01-25 |
| IL130052A0 (en) | 2000-02-29 |
| NZ508246A (en) | 2004-12-24 |
| DK0985414T3 (da) | 2003-12-29 |
| EP0985414A3 (de) | 2000-04-05 |
| CA2272665A1 (en) | 1999-11-26 |
| CA2272665C (en) | 2003-08-05 |
| AU762037B2 (en) | 2003-06-19 |
| TW581678B (en) | 2004-04-01 |
| ES2204067T3 (es) | 2004-04-16 |
| HUP9901728A3 (en) | 2001-01-29 |
| PT985414E (pt) | 2004-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600834D0 (en) | Quinazoline derivatives | |
| DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| OA09334A (fr) | "Dérivés d'acides aminés". | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| PT928788E (pt) | Compostos farmaceuticamente activos | |
| DE69623899D1 (de) | Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen | |
| PT992509E (pt) | Novos derivados macrolidos | |
| DE69429591D1 (de) | Therapeutisch wirksame Verbindungen | |
| YU224790A (sh) | Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila | |
| SE0102440D0 (sv) | New compound | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| ATE247963T1 (de) | Medikament zur behandlung von glaukoma und ischämischer retinopathie | |
| DK1209166T3 (da) | Hidtil ukendte A-500 359-derivater | |
| ATE359995T1 (de) | Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit | |
| TR200102009T2 (tr) | Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı | |
| EP2266566A3 (de) | Nicotinamid Derivate und ihrer Verwendung als Therapeutika | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| DE69908855D1 (de) | 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin | |
| US6541495B1 (en) | Carboxylic acid derivatives as inhibitors of hyperproliferation diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0985414 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |